# Filing Detail

Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001104659-23-052074
Filing Date
2023-04-28
Accepted
2023-04-28 07:31:54
Documents
1
Period of Report
2022-12-31
Effectiveness Date
2023-04-28

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ARS | tm2313579d2_ars.pdf | ARS | 1581222
| Complete submission text file | 0001104659-23-052074.txt |  | 2179627

Mailing Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104 2674916422
Carisma Therapeutics Inc. (Filer) CIK: 0001485003 (see all company filings)

EIN.: 262025616 | State of Incorp.: PA | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-36296 | Film No.: 23860193
SIC: 2834 Pharmaceutical Preparations